Perrigo Results Reach A Valley Before Peak Expected From Opill Launch, Private Label Gains

Perrigo investing in preparing marketplace for Opill and educating consumers about it and reports trend of sales volumes increasing for private label/store brand consumer health portfolio.

• Source: Shutterstock

Perrigo Company PLC’s marketing of national brands on top of its leading private label and store brand portfolio is encountering a downside before reaching the expected upside of results showing the best of both worlds.

On one hand, while the firm’s launch of sales of the first US OTC daily oral contraceptive branded Opill, planned...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Rx-to-OTC Switch

More from Health